About This GxP-CC Webinar Series
Join our 3-part expert-led webinar series to navigate the most important regulatory changes impacting pharmaceutical compliance in 2025.
With the draft updates to Chapter 4 and Annex 11 - and the groundbreaking release of Annex 22 on Artificial Intelligence - the EU-GMP landscape is evolving rapidly. This series is your guide to understanding what’s changing, why it matters, and how to adapt your systems, SOPs, and quality strategies accordingly.
Each session focuses on a different guideline, providing practical interpretations, compliance insights, and real-world recommendations from consultants actively working in regulated environments.